Skip to content
Delayed ~15 min

PROK PROKIDNEY CORP CLASS A

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Mon 9 Nov 2026 · estimated

What 6 analyst firms say about PROKIDNEY CORP CLASS A: their latest ratings, price targets and how far the stock is from them. How it works

1.14 USD+0.08 (+7.04%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+590.8%to the avg target 7.88 USD+6.74 USD
Buy 4 · Hold 1 · Sell 0

5 rated views · 6 analyst/firm records · 6 firms

Latest report28 Oct 2026avg report date 25 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)

Recent analyst activity · last 90 days

Our tracked history has 4 reports on PROK from 4 analyst firms in the last 90 days (6 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
CitigroupYigal NochomovitzBuy28 Oct 20268.00 USD
GuggenheimVamil DivanBuy11 Aug 20267.00 USD
H.C. WainwrightJoseph PantginisBuy11 Aug 202612.00 USD
JefferiesAndrew TsaiBuy18 Mar 20264.50 USD
Weiss RatingsUnnamed analyst—6 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 03:39 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.